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Abstract
Objective: to identify possible risk factors associated with wheezing in infants (12-15 months-
old) in the state of Mato Grosso, Brazil.
Methods: this was a cross-sectional study performed by applying a standardized written ques-
tionnaire from the international study on wheezing in infants (Estudio Internacional de Sibilancia
en Lactantes - EISL), phase 3. Parents and/or guardians of infants were interviewed at primary
health care clinics or at home from August of 2009 to November of 2010. Factors associated to
wheezing were studied using bivariate and multivariate analysis (using the Statistical Package
for Social Sciences [SPSS] v.18.0), and expressed as odds ratios (OR) and 95% conﬁdence intervals
(95% CI).
Results: the written questionnaire was answered by 1,060 parents and/or guardians. The risk
factors for wheezing were: history of asthma in the family [mother (OR = 1.62; 95% CI = 1.07-
2.43); father (OR = 1.98; 95% CI = 1.22-3.23); siblings (OR = 2.13; 95% CI = 1.18-3.87)]; history
of previous pneumonia (OR = 10.80; 95% CI = 4.52-25.77); having had more than six upper
respiratory tract infections (URTIs) (OR = 2.95; 95% CI = 2.11-4.14); having had ﬁrst URTI before
the third month of life (OR = 1.50; 95% CI = 1.04-2.17); living in a moderately polluted area
(OR = 1.59; 95% CI = 1.08-2.33); paracetamol use for URTI (OR = 2.13; 95% CI = 1.54-2.95); and
antibiotic use for skin infection (OR = 2.29; 95% CI = 1.18-4.46).
Conclusions: the study of risk factors for wheezing in the ﬁrst year of life is important to help
physicians identify young children at high risk of developing asthma and to improve public health
prevention strategies in order to reduce the morbidity of wheezing in childhood.
© 2013 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda. All rights reserved.
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Resumo
Objetivo: identiﬁcar possíveis fatores de risco associados à sibilância em lactentes (12 a 15
meses) no estado de Mato Grosso, Brasil.
Métodos: estudo transversal, utilizando o questionário escrito padronizado do Estudio Inter-
nacional de Sibilancia en Lactantes (EISL) -- fase 3. Pais e/ou responsáveis pela crianc¸a foram
entrevistados em Unidades Básicas de Saúde quando as procuravam para imunizac¸ão de rotina
ou durante visitas nos domicílios de crianc¸as matriculadas nos programas de saúde da família,
no período de agosto de 2009 a novembro de 2010. Fatores associados à sibilância foram avali-
ados utilizando análise bivariada e multivariada e expressos como odds ratio (OR) e intervalo
de conﬁanc¸a 95% (IC95%).
Resultados: ao todo, um mil e sessenta (n = 1.060) pais e/ou responsáveis responderam o
questionário escrito. Os fatores de risco para sibilância foram: história familiar de asma [mãe
(OR = 1,62; IC95%= 1,07-2,43); pai (OR = 1,98; IC95% = 1,22-3,23); irmãos (OR = 2,13; IC95% =
1,18-3,87)]; história prévia de pneumonia (OR = 10,8; IC 95% = 4,52-25,77); ter mais de seis
infecc¸ões de vias aéreas superiores (IVAS) (OR = 2,95; IC95% = 2,11-4,14) e a primeira IVAS antes
dos três meses de idade (OR = 1,50; IC95% = 1,04-2,17); residir em local com moderada poluic¸ão
(OR = 1,59; IC95% = 1,08-2,33); uso de paracetamol por IVAS (OR = 2,13; IC95% = 1,54-2,95); e
uso de antibiótico por infecc¸ão na pele (OR = 2,29; IC 95% = 1,18-4,46).
Conclusões: O estudo dos fatores de risco para sibilância no primeiro ano de vida é importante
para auxiliar na identiﬁcac¸ão, entre os lactentes sibilantes, aqueles de alto risco para desen-
volver asma, e para o desenvolvimento de estratégias de prevenc¸ão por políticas pública de
saúde visando minimizar a morbidade da sibilância na infância.
© 2013 Sociedade Brasileira de Pediatria. Publicado por Elsevier Editora Ltda. Todos os direitos
reservados.
Introduction
Wheezing in infants is an important cause of morbidity
worldwide, both in developed and developing countries.1
Some wheezing phenotypes have been described as associ-
ated with different risk factors.2 In infants and preschool
children, the asthma diagnosis is based on clinical symp-
toms, presence of risk factors, and therapeutic response;
therefore, the identiﬁcation, among wheezing infants, of
those at high risk for developing asthma is crucial to deﬁne
which children will beneﬁt from preventive or therapeutic
interventions.3
Prospective studies suggest several risk factors for early
wheezing in children and its association with the subsequent
development of asthma, such as family history of allergy,4
personal history of rhinitis or eczema,5,6 maternal smok-
ing during pregnancy or passive exposure after birth,7 male
gender,2,5 viral respiratory infections by respiratory syncytial
virus (RSV) or rhinovirus,8,9 and attending daycare.10 Epi-
demiological studies have observed an association between
the development of asthma and regular use of medications
such as paracetamol and antibiotics during infancy.11,12
Therefore, risk factors for wheezing in infants have
been identiﬁed, but their analysis is complex, due to the
genetic-environmental interactions. The development of
methods to identify and quantify these factors is essential
for better understanding the natural history of asthma in
childhood. The epidemiology of asthma is known worldwide
in school-age children, adolescents, and adults; however,
the prevalence and risk factors associated with symptoms
of recurrent wheezing in infants and preschool children are
still under investigation.13
To assess the impact of recurrent wheezing in infants and
determine its prevalence and associated risk factors, the
International Study of Wheezing in Infants in the ﬁrst year
of life (Estudio Internacional de Sibilancias en Lactantes -
EISL) was developed. This is an international multicenter
study with the participation of Latin American countries,
Spain, and the Netherlands, whose tool was a standardized
questionnaire validated in all participating centers. Phase
1 of EISL used a standardized questionnaire with 45 ques-
tions on demographic characteristics, respiratory symptoms,
use of medications, and possible risk factors associated with
wheezing.1 Phase 2 was designed to verify the onset and per-
sistence of wheezing in preschoolers among the children who
participated in Phase 1, and the centers that participated
have not yet published their results. Phase 3 was designed to
be conducted ﬁve years after Phase 1 in the same region, to
compare the trend in prevalence in relation to Phase 1 data,
and it used the same questionnaire as in Phase 1, including
ﬁve questions on the use of antibiotics and paracetamol in
ﬁrst months of life, totaling 50 questions.
This study aimed to evaluate risk factors associated with
wheezing in infants in Midwestern Brazil, using the standard-
ized protocol of EISL - Phase 3.
Patients and methods
Parents or guardians of healthy infants aged 12 to 15 months
who answered the standard written questionnaire of EISL
(QE-EISL) - Phase 3 participated in the study.
Among the 60 basic health units (BHUs) distributed in four
regions - North, South, East and West - of the city, 28 were
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randomly selected for the study. Parents and/or guardians
were invited to participate when they came for consultation
and routine immunization of their children, or during visits
to households of all children aged 12 to 15 months enrolled in
the Family Health Program of the BHUs. All parents and/or
guardians agreed to participate, signed an informed con-
sent, and were then interviewed by the main investigator or
a previously trained medical student. Visits to the BHUs or
homes occurred between August of 2009 and November of
2010; during the two immunization campaigns against polio
performed during this period, all children who belonged to
the target age group that came on the day of the campaign
participated in the study.
The QE-EISL - phase 3 is a tool consisting of 50 ques-
tions regarding demographic characteristics, wheezing, and
risk factors, translated into Portuguese and validated for the
Brazilian population.14
To perform the study, the coordinators of the EISL stipu-
lated that the sample should include at least 1,000 infants.
The sample size was based on the International Study of
Asthma and Allergies in Childhood (ISAAC), considering a
prevalence of wheezing of 30% and 25% in two different cen-
ters, with a study power of 95% and a signiﬁcance level of 1%
for this sample, to ensure adequate power for comparisons
between centers and countries, even for questions with a
low prevalence of positive answers.1,15
Infants who had three or more episodes of wheezing were
deemed recurrent wheezers and those with less than three
episodes of wheezing were termed occasional wheezers.
Those who never had a wheezing episode were classiﬁed
as non-wheezers.
Data were coded in a standard way, transferred to a
database developed in Microsoft Excel® 2007, and statis-
tically analyzed using the Statistical Package for Social
Sciences (SPSS) for Windows - release 18.0.
Non-parametric tests were used (chi-squared and Fisher’s
exact test), as well as logistic regression model. Estimates
of prevalence ratio with a 95% conﬁdence interval (95% CI)
were calculated in the bivariate analysis. The Poisson model
was used for the logistic regression to evaluate the factors
associated with the presence or absence of wheezing. In the
initial model, the variables that resulted in a p < 0.20 in the
bivariate analysis were identiﬁed. For multivariate analysis,
the backward technique was used and the test for variable
input and output was the likelihood ratio, with p < 0.05, thus
determining the ﬁnal model. All signiﬁcance probabilities
were bilateral, with a signiﬁcance level of 0.05 in all tests.
This study was approved by the Ethics Committee of the
Universidade Federal de São Paulo/Escola Paulista de Medi-
cina (UNIFESP/EPM) and the Research Ethics Committee of
the Hospital Universitário Júlio Müller.
Results
A total of 1,060 parents and/or guardians of infants aged
between 12 and 15 months were interviewed. No question-
naires were excluded from the sample due to incorrect
completion. Most responders were mothers (87.9%), fol-
lowed by other relatives (6.4%), and fathers (5.7%). Five
hundred and forty-six (51.5%) were females and 514 (48.5%)
were males. Two hundred and ninety-four (27.7%) infants
had at least one episode of wheezing in the ﬁrst year of
life (‘‘wheezers’’), with wheezing onset at 5.8±3.0 months.
Among the wheezing infants, 159 (54.1%) had less than three
episodes (occasional wheezing) and 135 (45.9%) had three or
more episodes (recurrent wheezing).
Table 1 shows the factors that were associated with
wheezing in the ﬁrst 12 months of life in the bivariate
analysis, which were: male gender, history of pneumonia
and hospitalization for pneumonia, exposure to maternal
smoking during pregnancy and passive exposure after birth,
family history of asthma, daily consumption of industrial-
ized foods, breastfeeding duration between two and four
months, more than six upper respiratory tract infections
(URTIs), having the ﬁrst URTI before three months of life,
living in a moderately polluted environment, presence of at
least one sibling in the household, household income less
than R$ 800.00, use of antibiotics for pneumonia and skin
infections, and use of paracetamol for URTI.
Factors associated with recurrent wheezing in the bivari-
ate analysis were: antibiotics for bronchitis, antibiotics for
any infection, use of paracetamol for bronchitis, and para-
cetamol use more than seven times in the ﬁrst year of life
(Table 2).
Table 3 and Fig. 1 show the results of the multivariate
analysis. Odds ratios (OR) and corresponding 95% conﬁdence
intervals (95%CI) were calculated. Independent risk factors
associated with the presence of at least one episode of
wheezing in the ﬁrst year of life were: history of pneu-
monia, family history of asthma in the mother, father and
siblings, more than six URTIs, ﬁrst URTI before three months
of life, living in a moderately polluted environment, antibi-
otic use for skin infections, and paracetamol use for URTIs.
The protective factors for wheezing in the ﬁrst year of life
were: C-section delivery, indoor bathroom, mother having
paid work, and taking antibiotics for pneumonia.
Discussion
Genetic and environmental factors have been suggested as
risk factors for wheezing in the ﬁrst years of life. As wheez-
ing is the main symptom of asthma, identifying these factors
in this age group is crucial for a better understanding of
the different wheezing phenotypes and the progression to
asthma development. The results of this study point to
several genetic, demographic, and environmental factors
associated with wheezing in the ﬁrst year of life.
Among the sociodemographic factors, male gender was
a risk factor for the occurrence of at least one episode
of wheezing in infants evaluated in the bivariate anal-
ysis (Table 1). Other Brazilian studies also found this
association.16,17 This factor, however, did not remain a risk
factor in the multivariate analysis; a similar ﬁnding was
observed in another Brazilian study.18
In this study, the presence of asthma in the infants’ rela-
tives (mother, father, and siblings) was associated with risk
of wheezing in the ﬁrst year of life in both the bivariate and
multivariate analyses. In a Brazilian cohort study, family his-
tory of asthma assessed at four years of age was signiﬁcantly
associated with the pattern of transient and persistent
wheezing.5 Other studies have found this association16--18,
in agreement with the Asthma Predictive Index (API), which
562 Moraes LS et al.
Table 1 Factors associated with the presence of at least one episode of wheezing in the ﬁrst 12 months of life (n = 294) in the
bivariate analysis.
Factors n PR 95% CI p
Male gender 159 1.36 1.04-1.79 0.029
Pneumonia 80 3.90 2.72-5.58 0.000
Hospitalization due to pneumonia 33 3.91 2.27-6.73 0.000
Passive smoking 94 1.58 1.17-2.12 0.003
Maternal smoking during pregnancy 16 2.15 1.10-4.20 0.023
Asthma in the family
Father 37 1.79 1.16-2.77 0.012
Mother 57 1.58 1.11-2.26 0.015
Sibling 26 2.15 1.26-3.67 0.006
Daily intake of industrialized food 139 1.42 1.09-1.87 0.013
URTIs
≥ six episodes a year 125 3.90 2.89-5.28 0.000
First episode before three months of life 86 2.06 1.50-2.82 0.000
First episode after six months of life 64 0.53 0.39-0.72 0.000
C-section delivery 212 0.44 0.30-0.57 0.000
Mother’s level of schooling: complete high
school or college/university
94 0.66 0.50-0.88 0.005
Air conditioning at home 135 0.46 0.35-0.60 0.000
Indoor bathroom 262 0.26 0.15-0.46 0.000
Live in a moderately polluted environment 68 1.79 1.28-2.52 0.001
Have at least one sibling 180 1.50 1.14-1.97 0.005
Mother has a job 138 0.63 0.48-0.83 0.001
Family income < R$ 800.00 71 2.25 1.60-3.17 0.000
Family income of R$ 3,500.00 to R$ 5,000.00 43 0.60 0.42-0.87 0.008
Updated immunizations 266 0.47 0.28-0.78 0.005
Antibiotic use
Due to pneumonia 53 2.63 1.77-3.93 0.000
Due to otitis 49 1.76 1.20-2.56 0.004
Due to skin infection 22 2.40 1.33-4.32 0.004
Paracetamol use
Due to URTIs 211 2.62 1.96-3.51 0.000
Due to pneumonia 22 4.68 2.33-9.43 0.000
Number of times that paracetamol was used
One to three times 65 0.64 0.47-0.88 0.006
Seven or more times 141 1.75 1.33-2.30 0.000
CI, conﬁdence interval; PR, prevalence ratio; URTIs, upper respiratory tract infections.
has parental history of asthma as a major criterion for the
diagnosis of asthma in children with recurrent wheezing.19
The presence of six or more episodes of upper respiratory
tract infections in the ﬁrst year of life, with early onset
(before three months of age), was a factor associated with
wheezing in this study (Tables 1 and 3). The presence of
at least one sibling in the house, which was also associated
with wheezing in the bivariate analysis, may partly explain
the early occurrence of these infections, as only 31 (10.5%)
of the infants who had at least one episode of wheezing
attended daycare (data not shown).
Upper and lower airway infections, particularly those
caused by RSV and rhinoviruses, are common triggers of
wheezing in childhood, but the role of early infection in the
subsequent development of asthma is less clear.20 The EISL
- Phase 1, which involved 28,687 infants from countries in
Latin America and Europe, observed the presence of URTI
in the ﬁrst three months of life among the risk factors for
occasional and recurrent wheezing.1 A cohort study that
evaluated 2,319 infants up to two years of age found that
children who had common colds in the ﬁrst three months
of life had high risk for experiencing wheezing in the sec-
ond year of life.21 Another study found that the number of
respiratory infections, particularly in the ﬁrst two years of
life, showed an almost linear association with the risk of
subsequent asthma, and that the group of children who had
nine to ten infections had an almost eight-fold higher risk
for development of asthma.22
The reporting of pneumonia was associated with wheez-
ing in both the bivariate and multivariate analyses
(Tables 1 and 3). As this was a cross-sectional study, wheez-
ing could not be characterized as a triggering or consequent
factor of pulmonary infections, but pneumonia was an
important risk factor in this study. In a cohort of newborns of
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Table 2 Factors associated with occasional (less than three episodes of wheezing, n = 159) and recurrent wheezing (three or
more episodes of wheezing, n = 135) in the ﬁrst year of life in the bivariate analysis.
Variables Wheezing in the ﬁrst year of life
Occasional Recurrent
OR 95% CI OR 95% CI
Upper respiratory tract infections
First episode > six months of life 2.65 1.45-4.84 0.38 0.21-0.69
Use of antibiotics in the ﬁrst year of life
Due to bronchitis 0.42 0.26-0.68 2.36 1.46-3.81
Due to any other infection 0.41 0.25-0.66 2.46 1.51-4.00
Use of paracetamol in the ﬁrst year of life
One to three times 1.90 1.07-3.38 0.52 0.29-0.93
Seven or more times 0.57 0.36-0.90 1.76 1.11-2.80
Due to bronchitis 0.48 0.27-0.84 2.08 1.18-3.64
CI, conﬁdence interval; OR, odds ratio.
Table 3 Factors associated with wheezing in the ﬁrst year of life in the multivariate analysis (n = 294).
Variables OR 95% CI pa
Pneumonia 10.80 4.52-27.77 0.000
Father has asthma 1.98 1.22-3.23 0.006
Mother has asthma 1.62 1.07-2.43 0.021
Sibling has asthma 2.13 1.18-3.87 0.013
C-section delivery 0.66 0.45-0.98 0.037
Six or more episodes of URTIs 2.95 2.11-4.14 0.000
First URTI before three months of life 1.50 1.04-2.17 0.029
Indoor bathroom 0.41 0.22-0.76 0.005
Live in a moderately polluted environment 1.59 1.08-2.33 0.018
Mother has a job 0.66 0.48-0.90 0.009
Antibiotic use due to pneumonia 0.22 0.08-0.56 0.002
Antibiotic use due to skin infection 2.29 1.18-4.46 0.015
Paracetamol use due to URTI 2.13 1.54-2.95 0.000
CI, conﬁdence interval; OR, odds ratio; URTIs, upper respiratory tract infections.
a Signiﬁcant values.
Pneumonia (OR=10.80) 0.000
Father has asthma (OR=1.98) 0.006
Mother has asthma (OR=1.62) 0.021
Siblings have asthma (OR=2.13) 0.013
C-section delivery (OR=0.66) 0.037
Six or more episodes of URTIs (OR=2.95) 0.000
URTI in the first three months of life (OR=1.50) 0.029
Indoor bathroom (OR=0.41) 0.005
Live in a moderately polluted area (OR=1.59) 0.018
Mother has a job (OR=0.66) 0.009
Antibiotic use due to pneumonia (OR=0.22) 0.002
Antibiotic use due to skin infection (OR=2.29) 0.015
Paracetamol use due to URTI (OR=2.13) 0.000
OR: odds ratio; URTI: Upper respiratory tract infection
pRiskProtection
Wheezing
1.51.00.50.0 2.0 2.5 3.0 3.5 4.0 4.5 5.0 5.5 6.0
Figure 1 Risk and protective factors for wheezing in the ﬁrst year of life.
564 Moraes LS et al.
low socioeconomic class in Santiago (Chile), followed during
the ﬁrst year of life, a prevalence of pneumonia of 13.3%,
was observed, and the presence of recurrent wheezing dur-
ing the ﬁrst three months of life was strongly associated with
the diagnosis of pneumonia.23 EISL publications in Brazil also
found the presence of pneumonia in the ﬁrst year of life as
a risk factor associated with wheezing.17,18,24
In the present study, exposure to maternal smoking
during pregnancy and passive exposure after birth was asso-
ciated with wheezing only in the bivariate analysis (Table 1).
The multivariate analysis did not conﬁrm this association,
which can be explained by the low frequency of mothers
of wheezing infants who smoked during pregnancy (5.4%) or
after birth (7.5%). There is a tendency towards undernotiﬁ-
cation of the frequency of smoking by parents and caregivers
of children with respiratory diseases, as they know the harm-
ful effects of smoking on the respiratory system.
Obtaining objective measures of this exposure could min-
imize this bias. Exposure to cigarette smoke, both in the
prenatal period and after birth, was associated with the
risk of wheezing in infants and preschool children in sev-
eral studies.1,17,25 A meta-analysis observed that prenatal or
postnatal exposure increased the risk of incidence of wheez-
ing by 30% to 70%, mainly in children younger than two
years, stressing that parental smoking prevention is crucial
for asthma prevention.7
The present study demonstrated that living in a moder-
ately polluted environment was a risk factor for wheezing
in the ﬁrst year of life, similar to that observed in other
studies.18,26 Exposure to pollutants may be associated with
respiratory symptoms such as wheezing, not only as a trigg-
ering factor, but also as a risk factor for the development of
asthma, according to the results of a cohort study of 4,089
Swedish children, which demonstrated that exposure to air
pollution from trafﬁc during the ﬁrst year of life was associ-
ated with risk of persistent wheezing and low lung function
at the age of 4 years.27 In a Chilean cohort study, the preva-
lence of wheezing in the ﬁrst year of life was high (80.3%),
and it was observed that 82.2% of the children were exposed
to pollutants resulting from the fuel used for heating or
cooking (kerosene, gas), and that 38.5% of the homes were
located on unpaved roads.23 As the pollution exposure was
known only through parental report, this result must be ana-
lyzed with caution, as it lacks objective measures to assess
the degree of intra- and extra-domiciliary environment pol-
lution.
In this study, the use of drugs such as paracetamol and
antibiotics was associated with the risk of recurrent wheez-
ing (Table 2) and of wheezing in the ﬁrst year of life (Table 3).
A prospective study that followed children with a family
history of atopy, from birth to 7 years of age, found an asso-
ciation between frequency of paracetamol use and asthma
development, which was not maintained after adjustment
for the frequency of respiratory infections, suggesting a
confounding factor i.e., it is likely that the viral infec-
tions in early childhood, more than the use of paracetamol,
may lead to the development of asthma.28 However, in
another study, the association between asthma and para-
cetamol use persisted even after adjusting for respiratory
infections.29 A cohort study that evaluated the use of para-
cetamol during pregnancy observed that the use of this drug
was associated with the presence of asthma at age ﬁve and
the risk was higher in those who had a greater number of
days of consumption, suggesting a possible dose-dependent
association.30
Therefore, the association between paracetamol and
wheezing/asthma may simply reﬂect a reverse causality, i.e.
children with a genetic predisposition to asthma or other
allergies are more prone to febrile comorbidities, particu-
larly URTI and therefore use more antipyretic medications
such as acetaminophen.11 Thus, the association between
paracetamol and wheezing/asthma requires further stud-
ies, using more appropriate designs that can attenuate or
eliminate potential confounding biases.
The use of antibiotics was a risk factor for wheezing, and
this can be explained in part by the ‘‘hygiene hypothesis’’,
which suggests that children who grow up in an environment
with less microbial exposure tend to be more atopic and
therefore have a greater chance of developing asthma.31 A
meta-analysis study observed that exposure to at least one
course of antibiotics in the ﬁrst year of life was a risk fac-
tor for the development of asthma in childhood.32 A cohort
study of 251,817 Canadian children followed from birth,
evaluated for exposure to antibiotics in the ﬁrst year of life,
observed a lower risk for developing asthma, but this risk
increased greatly when the child received more than four
courses of antibiotics in the study period.33 Another recent
meta-analysis evaluating antibiotic exposure in the prena-
tal period and the ﬁrst year of life found an association with
asthma from ages 3 to 18 years.34
In fact, several studies show a signiﬁcant association
between the use of antibiotics in early childhood and sub-
sequent development of wheezing/asthma; conversely, the
use of antibiotics may be a consequence of the increased
frequency of respiratory infections in children with allergic
predisposition, which is postulated as reverse causality, and
this may complicate the interpretation of several epidemi-
ological studies; therefore, further studies are needed to
elucidate this association.
The present study had some limitations that should be
considered when interpreting the results. As this was a
cross-sectional study, the associations observed cannot be
considered as causalities, and prospective studies are neces-
sary to better clarify the correlation between risk factors for
wheezing and/or asthma. A strong aspect of the study was
that the information regarding the wheezing that occurred
in the ﬁrst 12 months of life was obtained when the infants
were 12 to 15 months, thereby decreasing the likelihood of
recall bias. Other important aspects of this study were the
sample size and the use of a standardized questionnaire that
allowed for the comparison between the different centers
which performed the study.
In conclusion, this study demonstrated that some factors
were associated with risk of wheezing in the ﬁrst year of life,
such as family history of asthma, pneumonia, more than six
episodes of upper respiratory infections in early life, liv-
ing in a polluted environment, and use of paracetamol and
antibiotics. These factors varied when compared with other
Brazilian studies that used the same protocol, which rein-
forces the need for further studies in other cities of Brazil
due to the environmental particularities of each region.
Prospective follow-ups of wheezing infants are needed to
analyze the impact of these risk factors over the long-term
in Brazil. The identiﬁcation of risk factors for wheezing in
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the ﬁrst years of life is crucial not only for the diagno-
sis of asthma, but also for the development of prevention
strategies through public health policies aiming to minimize
wheezing morbidity in childhood.
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